These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37955351)

  • 1. A case of generalized pustular psoriasis with discrepant resolution time between pustules and erythema after treatment with spesolimab.
    Matsuo M; Niwa H; Onishi H; Iwata H
    J Dermatol; 2024 Apr; 51(4):e127-e128. PubMed ID: 37955351
    [No Abstract]   [Full Text] [Related]  

  • 2. [Remission of recalcitrant generalized pustular psoriasis under interleukin-36 receptor inhibitor spesolimab].
    Müller VL; Kreuter A
    Dermatologie (Heidelb); 2023 May; 74(5):356-359. PubMed ID: 36943426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study.
    Morita A; Tsai TF; Yee EYW; Okubo Y; Imafuku S; Zheng M; Li L; Quaresma M; Thoma C; Choon SE
    J Dermatol; 2023 Feb; 50(2):183-194. PubMed ID: 36282833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares in Adult Patients.
    Bukhari T; Markovina M; Abduelmula A; Rankin BD; Vender R; Yeung J; Devani AR; Prajapati VH
    Skin Therapy Lett; 2024 Jan; 29(1):1-4. PubMed ID: 38271532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
    Hawkes JE; Visvanathan S; Krueger JG
    Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
    Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
    J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infantile generalized pustular psoriasis: successful disease control with intermittent etretinate.
    Namba C; Murakami M; Hanakawa Y; Tohyama M; Shirakata Y; Tauchi H; Sayama K
    J Dermatol; 2014 May; 41(5):403-6. PubMed ID: 24801915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of Spesolimab for Generalized Pustular Psoriasis.
    Bachelez H; Choon SE; Marrakchi S; Burden AD; Tsai TF; Morita A; Navarini AA; Zheng M; Xu J; Turki H; Anadkat MJ; Rajeswari S; Hua H; Vulcu SD; Hall D; Tetzlaff K; Thoma C; Lebwohl MG;
    N Engl J Med; 2021 Dec; 385(26):2431-2440. PubMed ID: 34936739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
    Bernardo D; Thaçi D; Torres T
    Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors.
    Maçães CO; Lé AM; Torres T
    J Dermatolog Treat; 2022 Nov; 33(7):2911-2918. PubMed ID: 35695278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spevigo® (Spesolimab-Sbzo) Injection for the Treatment of Generalized Pustular Psoriasis.
    Gupta AK; Mann A; Vincent K; Abramovits W
    Skinmed; 2024; 22(2):134-137. PubMed ID: 39089999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
    Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD
    Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized pustular psoriasis rapidly and successfully treated with ixekizumab in a Caucasian patient.
    Megna M; Abategiovanni L; Annunziata A; Torta G; Peduto T; Fabbrocini G; Lauro W
    Dermatol Ther; 2022 May; 35(5):e15382. PubMed ID: 35170168
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study.
    Elewski BE; Lebwohl MG; Anadkat MJ; Barker J; Ghoreschi K; Imafuku S; Mrowietz U; Li L; Quaresma M; Thoma C; Bachelez H
    J Am Acad Dermatol; 2023 Jul; 89(1):36-44. PubMed ID: 36870370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized pustular psoriasis recurring during pregnancy and lactation successfully treated with ixekizumab.
    Huang D; Liu T; Li J; Lu Y; Ma H
    Dermatol Ther; 2022 Dec; 35(12):e15878. PubMed ID: 36181408
    [No Abstract]   [Full Text] [Related]  

  • 16. Generalized pustular psoriasis patient with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab.
    Ogawa Y; Maejima E; Takeichi T; Okamoto T; Mitsui H; Shimada S; Akiyama M; Kawamura T
    J Dermatol; 2024 Sep; ():. PubMed ID: 39301845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment of Recurrent Pustular Psoriasis of Pregnancy with Secukinumab: A Case Report.
    Liu N; Zhu L; Cheng Y; Yu N; Yi X; Ding Y
    Acta Derm Venereol; 2020 Aug; 100(15):adv00251. PubMed ID: 32812054
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of generalized pustular psoriasis complicated with SLE successfully treated with spesolimab.
    Minami Y; Shinkuma S; Yokoyama T; Shinoda S; Hamada K; Arima A; Ogawa K; Miyagawa F; Asada H
    J Dermatol; 2024 Oct; 51(10):e335-e336. PubMed ID: 38680031
    [No Abstract]   [Full Text] [Related]  

  • 19. Spesolimab: A Novel Treatment for Pustular Psoriasis.
    Ratnarajah K; Jfri A; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(2):199-200. PubMed ID: 32208020
    [No Abstract]   [Full Text] [Related]  

  • 20. Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis.
    Burden AD
    Expert Rev Clin Immunol; 2023 May; 19(5):473-481. PubMed ID: 36960829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.